All Articles

Triller's audacious acquisition of a SpaceX stake sends its stock soaring, but can this high-stakes bet on a space giant save a company plagued by financial woes?

A novel membrane technology promises to speed up production of next-gen medicines by solving a critical, energy-intensive bottleneck in pharmaceutical manufacturing.

A new deal in Israel signals a shift from noisy, ineffective warnings to precise, life-saving insights. Is this the future of personalized medication safety?

As construction firm JFB Holdings pivots to AI combat, its partner XTEND lands major defense deals, revealing a potent growth model for the autonomous age.

An independent safety board just gave Medera's novel gene therapy for a stubborn form of heart failure a major endorsement, de-risking its path to the FDA.

The company once known for late-night snacks is pivoting hard, aiming to acquire a Taiwanese tech giant in a deal that could be worth over a billion dollars.

By combining vast datasets with patient-driven advocacy, a new alliance offers hope for angiosarcoma patients and a new model for rare disease research.

Trintech's new AI agents automate tedious financial analysis, but the real story is its push for 'governed autonomy' in a high-stakes AI arms race.

Mint Inc. and YAS Digital Group are launching a joint venture to insure AI. Can their data-driven model unlock the next wave of automation in Asia?

NeuroSense's PrimeC shows intriguing biomarker activity against Alzheimer's, targeting multiple disease pathways. Is this the shift away from single-target drugs?

With a stunning 106% IRR and key operational wins, Anfield is moving beyond promises. Is this the moment a US uranium junior proves its mettle?

Hatch BioFund's new investment in Princeton spinout Optimeos funds a novel nanoparticle platform that could solve one of medicine's biggest challenges.

For America's 250th, a new AI lets you 'chat' with George Washington. Is this the future of education or a high-tech historical minefield?

A new wearable from NeuroLife promises to personalize stroke and spinal cord injury rehab. Can this non-invasive sleeve bridge the gap in accessible care?

A pioneering partnership in Hong Kong is embedding insurance directly into robots, aiming to solve the biggest hurdle to automation and redefine the industry.

Elite Island Resorts' partnership with Antiguan star Causion is more than a music video; it's a masterclass in authentic marketing and cultural investment.

ZOIA and Meta Healthcare's alliance brings a ready-to-use liquid nutrition to the US, promising to ease the daily burden for those with a rare metabolic disorder.

Core & Main is shuffling its debt, swapping short-term loans for long-term notes. It's a key signal of de-risking and fueling its growth engine.

Alliant Insurance Services’ hire of Liana Schindler isn’t just a new SVP. It’s a calculated move reflecting a seismic shift in the employee benefits landscape.

Industrial giant Würth Industry USA extends its global art patronage to the U.S., launching a juried exhibition for Virginia's emerging student artists.